Ligand · L1E
L1E · N~1~-(4-chlorophenyl)-6-methyl-N~5~-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine
L1E, N~1~-(4-chlorophenyl)-6-methyl-N~5~-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine (C26 H19 Cl N8, 478.9 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- L1E
- Formula
- C26 H19 Cl N8
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L1E in 2 structures; the first of them:
- 3IDP · B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor · L1E B1 · binds ILE463, VAL471, ALA481, VAL482, LYS483, GLU501, VAL504, LEU505 and 12 more
- 3IDP · B-RAF V600E kinase domain in complex with an aminoisoquinoline inhibitor · L1E B1 · binds ILE463, VAL471, ALA481, VAL482, LYS483, GLU501, VAL504, LEU505 and 12 more
Residues it binds most
ILE 4, LEU 4, VAL 4, PHE 4, ALA 4, ASP 4, CYS 4, GLN 4, GLU 4, GLY 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.